Document is current
Any future updates will be listed below
-
Authors
Mzoughi, Slim https://orcid.org/0000-0002-5158-0389
Schwarz, Megan
Wang, Xuedi https://orcid.org/0009-0000-7238-745X
Demircioglu, Deniz https://orcid.org/0000-0001-7857-0407
Ulukaya, Gulay
Mohammed, Kevin https://orcid.org/0000-0002-9955-9407
Zorgati, Habiba https://orcid.org/0000-0001-9840-7156
Torre, Denis https://orcid.org/0000-0003-4615-223X
Tomalin, Lewis E. https://orcid.org/0000-0003-4545-7138
Di Tullio, Federico
Company, Carlos
Dramaretska, Yuliia https://orcid.org/0000-0002-9792-0465
Leushacke, Marc
Giotti, Bruno
Lannagan, Tamsin RM https://orcid.org/0000-0002-8206-8898
Lozano-Ojalvo, Daniel https://orcid.org/0000-0002-3524-2929
Karras, Panagiotis https://orcid.org/0000-0002-7642-0875
Vermeulen, Peter B.
Hasson, Dan
Sebra, Robert https://orcid.org/0000-0001-9267-2426
Tsankov, Alexander M. https://orcid.org/0000-0002-7955-4414
Sansom, Owen J. https://orcid.org/0000-0001-9540-3010
Marine, Jean-Christophe https://orcid.org/0000-0003-2433-9837
Barker, Nick https://orcid.org/0000-0003-3566-4475
Gargiulo, Gaetano https://orcid.org/0000-0001-5414-4251
Guccione, Ernesto https://orcid.org/0000-0001-7764-5307
- License Information
-
More Information
Article History
Received: 23 July 2024
Accepted: 11 December 2024
First Online: 10 February 2025
Competing interests
: E.G.’s laboratory received research funds from AZ and Prelude Therapeutics (for unrelated projects). E.G. is a cofounder and shareholder of Immunoa Pte. Ltd and cofounder shareholder, consultant and advisory board member of Prometeo Therapeutics. G.G. is inventor on the patent application no. EP18192715 by the MDC for the design and use of sLCRs. R.S. is cofounder and CEO of Panacent Bio, Inc. and equity holder in GeneDx, neither of which has contributed to or been involved in the research in this publication. The other authors declare no competing interests.
